Venous access in cancerology;Acces veineux en cancerologie

Presse Medicale

Volumn 27, Issue 33, 1998, Pages 1694-1701

  Lesimple, T ^a   Beguec J F ^b   Leveque J M ^a  

^a CENTRE EUGÈNE MARQUIS   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; UROKINASE; ANTINEOPLASTIC AGENT;

CENTRAL VEIN; ECHOGRAPHY; HEPARINIZATION; HUMAN; INFECTION; ONCOLOGY; PERIPHERAL VEIN; PHLEBOGRAPHY; REVIEW; THROMBUS; VASCULAR ACCESS; VEIN OCCLUSION; INTRAVENOUS DRUG ADMINISTRATION; NEOPLASM; PALLIATIVE THERAPY; RISK FACTOR;

ANTINEOPLASTIC AGENTS; HUMANS; INFECTION; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; NEOPLASMS; PALLIATIVE CARE; RISK FACTORS;

EID: 0032585215     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Eurin B. Accès veineux. Techniques, complications. Rev Prat 1995 ; 45:365-71.
2. Keohane PP, Attrill H, Northover J et al. Effect of catheter tunnelling and a nutrition nurse on catheter sepsis during parenteral nutrition. A controlled trial. Lancet 1983 ; ii:1388-90.
3. Decker MD, Edwards KM. Central venous catheter infections. Pediatr Clin North Am 1988 ; 35:579-612.
4. Pichard E, Cosset-Delaigue MF, Nitenberg G. Voies d'abord, confort et sécurité des patients sous chimiothérapie. Rev Prat 1988 ; 38:1081-7.
5. Albanese CT, Wiener ES. Venous access in pediatric oncology patients. Semin Surg Oncol 1993 ; 9:467-77.
6. Domart Y. Traitement des infections sur cathéter. Rev Prat 1993 ; 43:610-14.
7. Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995 ; 13:233-8.
8. Mueller BU, Skelton J, Callender DP et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992 ; 10:1943-8.
9. Groeger JS, Lucas AB, Thaler HT et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993 ; 119:1168-74.
10. Lemmers NWM, Gels ME, Sleijfer DT et al. Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy. J Clin Oncol 1996 ; 14:2916-22.
11. Nitenberg G, Antoun S, Escudier B, Leclercq B. Complications infectieuses liées aux abords veineux centraux. In: Les infections graves en onco-hématologie, Nitenberg G, Cordonnier C eds. Masson, Paris 1991 ; 55-73.
12. Pearson ML. Guideline for prevention of intravascular device-related infections. Infect Control Hosp Epidemiol 1996 ; 17:438-73.
13. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991 ; 338:339-43.
14. Mansfield PF, Hohn DC, Fornage BD et al. Complications and failures of subclavian-vein catheterization. N Engl J Med 1994 ; 331:1735-8.
15. Pucheu A, Leduc B, Sillet-Bach I et al. Thromboses veineuses profondes sur dispositifs de perfusion implantables. Etude prospective de 72 patients par échotomographie-doppler des veines du cou (jugulaire, sous-clavière et tronc brachio-céphalique veineux). Bull Cancer 1993 ; 80:680-8.
16. McGee WT, Ackerman BL, Rouben LR et al. Accurate placement of central venous catheters: a prospective, randomized, multicenter trial. Crit Care Med 1993 ; 21:1118-23.
17. Conly JM, Grieves K, Peters B. A prospective randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis 1989 ; 159:310-19.
18. Bern MM, Lokich JJ, Wallach SR et al. Very low doses of warfarin can prevent thrombosis in central venous catheter. Ann Intern Med 1990 ; 112:423-8.
19. Monreal M, Alastru A, Rull M et al. Upper extremities deep venous thrombosis in cancer patients with venous access device. Prophylaxis with a low molecular weight heparin. Thromb Haemost 1996 ; 75:251-3.
20. Anaissie E, Samonis G, Kontoyiannis D et al. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 1995 ; 14:134-7.
21. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer 1995 ; 75:1367-75.
22. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. J Parenter Enteral Nutr 1988 ; 12:185-9.
23. Wechsler RJ, Spirn PW, Conant EF, Steiner RM, Needleman L. Thrombosis and infection caused by thoracic venous catheters: pathogenesis and imaging findings. A J R 1993 ; 160:467-71.
24. Haire WD, Lieberman RP, Edney J et al. Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 1990 ; 66:900-8.
25. Baranowski L. Central venous access devices. Current technologies, uses and management strategies. J Intravenous Nurs 1993 ; 16:167-94.
26. Pucheu A, Dierhas M, Leduc B et al. Fibrinolyse des thromboses veineuses profondes sur dispositifs de perfusions implantables. A propos d'une série consécutive de 57 thromboses et de 32 fibinolyses. Bull Cancer 1996 ; 83:293-9.
27. Fraschini C, Jadeja J, Lawson M et al. Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. J Clin Oncol 1987 ; 5:672-8.
28. Nace CS, Ingle RJ Central venous catheter "pinch-off" and fracture: a review of two under-recognized complications. Oncology Nursing Forum 1993 ; 20:1227-36.
29. Haire WD, Lieberman RP, Lund GB et al. Obstructed central venous catheters. Restoring function with a 12-hour infusion of low-dose urokinase. Cancer 1990 ; 66:2279-85.
30. Gault DT. Extravasations injuries. Br J Plast Surg 1993 ; 46:91-6.